@GenScript@iGEM TB is the 9th leading cause of deaths all across the world. We aim to develop a cheap, efficient & accessible system for early diagnosis of MDR-TB before it becomes severe or fatal, helping India become TB free by 2025!
What about you? @igem_iisc@iGEMParisSaclay@iGEM_IISERKol
Today, we #WearWhite for a future #Immune2Cancer. Together, we can help raise awareness on the lifesaving potential of #immunotherapy. Read about Ludwig scientists’ life-changing research in the field here. https://t.co/fI0j6HZnMC
Nearly 6 million people have signed the ‘Revoke Article 50’ petition - including over 27,000 in Cambridge. I told Parliament that we must take this seriously, by revoking article 50 or through a #FinalSay referendum
Study led by Sara Zanivan reveals potential new target for anti-angiogenic therapy. @szanivan
Hypoxic cancer–associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling https://t.co/WlrvbJcF7r